2 For instance, non-recommended dose-reduced DOAC therapy was reported in 23.2% (2,423/10,426) of patients with AFib in the GARFIELD-AF registry.23 In the RIETE registry, among 4,716 patients receiving DOACs for acute VTE, 475 (10.1%) received a lower-than-recommended dose for acute treatment
Whats in the GLOW Peptide Stack: GHK-Cu, BPC-157, and TB-500 Every peptide in the glow stack peptide set plays a different research role, which is why labs study them together
There is no single correct amount more water simply spreads the same 20 mg of peptide across a larger volume, which makes small doses easier to measure accurately
Pugliese, G
Once reconstituted with bacteriostatic water, keep at 28C and use within 30 days
The DISCOVERY Study Johns Hopkins has been chosen as one of 15 sites from across the country to participate in this ground breaking study, sponsored by the National Institutes of Health